These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 19772941

  • 21. Oral health considerations in older women receiving oral bisphosphonate therapy.
    Lo JC, O'Ryan F, Yang J, Hararah MK, Gonzalez JR, Gordon N, Silver P, Ansfield A, Wang B, Go AS.
    J Am Geriatr Soc; 2011 May; 59(5):916-22. PubMed ID: 21539523
    [Abstract] [Full Text] [Related]

  • 22. [Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].
    Capsoni F.
    Reumatismo; 2008 May; 60(1):6-13. PubMed ID: 18432320
    [Abstract] [Full Text] [Related]

  • 23. How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.
    Migliorati CA, Mattos K, Palazzolo MJ.
    J Am Dent Assoc; 2010 May; 141(5):562-6. PubMed ID: 20436104
    [Abstract] [Full Text] [Related]

  • 24. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 25. Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature.
    Rustemeyer J, Bremerich A.
    Clin Oral Investig; 2010 Feb; 14(1):59-64. PubMed ID: 19495814
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
    Brooks JK, Gilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun; 103(6):780-6. PubMed ID: 17223592
    [Abstract] [Full Text] [Related]

  • 28. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
    Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ.
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497
    [Abstract] [Full Text] [Related]

  • 29. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C, Al-Nawas B, du Bois A, Buch L, Harter P, Grötz KA.
    Cancer; 2009 Apr 15; 115(8):1631-7. PubMed ID: 19156913
    [Abstract] [Full Text] [Related]

  • 30. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw.
    Kang HS, Lee JW, Kim JS.
    Clin Exp Dermatol; 2011 Aug 15; 36(6):624-7. PubMed ID: 21771007
    [Abstract] [Full Text] [Related]

  • 31. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb 15; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 32. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
    Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N.
    J Oral Maxillofac Surg; 2009 Apr 15; 67(4):850-5. PubMed ID: 19304045
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.
    Crépin S, Laroche ML, Sarry B, Merle L.
    Eur J Clin Pharmacol; 2010 Jun 15; 66(6):547-54. PubMed ID: 20437036
    [Abstract] [Full Text] [Related]

  • 35. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH, Seal B, Tangirala M, Jeffcoat MK, Watts NB, Hay JW.
    Gen Dent; 2010 Jun 15; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [Abstract] [Full Text] [Related]

  • 36. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    Marx RE, Cillo JE, Ulloa JJ.
    J Oral Maxillofac Surg; 2007 Dec 15; 65(12):2397-410. PubMed ID: 18022461
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
    Grbic JT, Landesberg R, Lin SQ, Mesenbrink P, Reid IR, Leung PC, Casas N, Recknor CP, Hua Y, Delmas PD, Eriksen EF, Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly Pivotal Fracture Trial Research Group.
    J Am Dent Assoc; 2008 Jan 15; 139(1):32-40. PubMed ID: 18167382
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.